Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Change in Receivables (2016 - 2025)

Purple Biotech has reported Change in Receivables over the past 7 years, most recently at $20.3 million for Q4 2022.

  • Quarterly Change in Receivables rose 297.98% to $20.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $36.1 million through Dec 2022, up 95.25% year-over-year, with the annual reading at -$6.5 million for FY2025, 35.59% up from the prior year.
  • Change in Receivables was $20.3 million for Q4 2022 at Purple Biotech, up from $4.8 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $20.3 million in Q4 2022 and troughed at -$3.3 million in Q4 2018.
  • The 5-year median for Change in Receivables is $3.4 million (2019), against an average of $4.0 million.
  • Year-over-year, Change in Receivables plummeted 92.15% in 2020 and then skyrocketed 2484.4% in 2021.
  • A 5-year view of Change in Receivables shows it stood at -$3.3 million in 2018, then skyrocketed by 199.04% to $3.3 million in 2019, then plummeted by 92.15% to $258000.0 in 2020, then surged by 1879.07% to $5.1 million in 2021, then soared by 297.98% to $20.3 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Change in Receivables are $20.3 million (Q4 2022), $4.8 million (Q3 2022), and $3.6 million (Q2 2022).